Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain (Q41992250)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1993

Language	Label	Description	Also known as
English	Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain	scientific article published on August 1993

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

0 references

author name string

Noble F

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Derrien M

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Roques BP

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

language of work or name

0 references

publication date

1 August 1993

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

109

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

1064-1070

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Distinct cholecystokinin receptors in brain and pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Enzyme-resistant CCK analogs with high affinities for central receptors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Two brain cholecystokinin receptors: implications for behavioral actions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

The role of CCK caerulein, and CCK antagonists in nociception

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

5 June 2018

In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

18 August 2018

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2175722

18 August 2018

Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal caps

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic and regulatory mechanisms of in vitro release of Met-enkephalin from the dorsal zone of the rat spinal cord

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CCK 8 analgesia and hyperalgesia after intrathecal administration in the rat: Comparison with CCK-related peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo release of CCK-8 from the dorsal horn of the rat: Inhibition by DAGOL

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of [3H] CCK4 binding sites in mouse and rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8401918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1476-5381.1993.TB13730.X

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41992250&oldid=1931551888"